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 Abstract   
Hormonal, metabolic and immunological changes occurring during pregnancy have significant effects on the 
function of the skin. Psoriasis is one of the most common dermatological diseases and it is known as a nonspecific 
dermatosis in pregnancy. 
The aim of this article is to present the importance of support in the course of psoriasis in pregnant women. Psoriasis 
may cause recurrent miscarriages, chronic hypertension, diabetes or obesity, leading to perinatal complications and 
premature birth. The coexistence of psoriasis and pregnancy requires emotional prophylaxis, as well as support and 
psychotherapeutic care. Medical staff requires knowledge of skin diseases and skills to assess a patient’s mental 
state.
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 Streszczenie 
Zmiany hormonalne, metaboliczne oraz immunologiczne występujące w okresie ciąży w istotny sposób wpływają 
na funkcjonowanie skóry. Łuszczyca należy do najczęstszych schorzeń dermatologicznych i zaliczana jest do 
nieswoistych dermatoz okresu ciąży. 
Celem artykułu jest przedstawienie znaczenia wsparcia w przebiegu łuszczycy u kobiet ciężarnych. Ciąża w róż-
ny sposób wpływa na przebieg łuszczycy. Łuszczyca może powodować wystąpienie nawracających poronień, 
przewlekłego nadciśnienia tętniczego, cukrzycy, otyłości prowadząc do wystąpienia powikłań okołoporodowych 
i  porodu przedwczesnego. W  sytuacji stwierdzenia współistnienia łuszczycy w  ciąży konieczne jest wdrożenie 
profilaktyki w sferze emocjonalnej i objęcie ciężarnych wsparciem i opieką psychoterapeutyczną. Wspieranie cię-
żarnej z łuszczycą wymaga od personelu medycznego umiejętności oceny stanu psychicznego kobiety oraz wiedzy 
w zakresie chorób skóry.
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Admission
Although	 pregnancy	 is	 a	 physiological	 phenomenon,	 it	
is	 nevertheless	 a	 time	 of	 difficult	 and	 psychological	 biological	
adaptation.	 Hormonal,	 metabolic	 and	 immunological	 changes	
occurring	 in	pregnancy	have	significant	effects	on	 the	 function	
of	the	skin.	Psoriasis	is	one	of	the	most	common	dermatological	
diseases	 and	 belongs	 to	 the	 group	 of	 nonspecific	 dermatoses	
of	 pregnancy.	 Numerous	 studies	 on	 the	 negative	 influence	 of	
psoriasis	 in	 the	 course	 of	 pregnancy	 confirm	 that	 pregnant	
women	need	adequate	support	system.	A	high	level	of		support	
significantly	 decreases	 stress	 and	 anxiety,	 limiting	 the	 number	
of	 medical	 complications	 in	 pregnancy,	 and	 has	 a	 positive	
influence	on	patient	well-being.	Identification	of	quantitative	and	









of	 complex	 etiopathogenesis.	 Approximately	 1-3%	 of	 the	















Numerous	 external	 and	 internal	 factors	 such	 as	 stress,	




Sex	 hormones	 (estrogens,	 progesterone	 and	 androgens),	
have	 a	 biological	 and	 immunological	 impact	 on	 the	 skin	
pathophysiology,	 so	pregnancy	 influences	 the	natural	course	of	
psoriasis	[13].












response	 (Th2),	 the	 production	 of	 blocking	 antibodies	 and	
physiologically	 increased	 levels	 of	 progesterone	 and	 estrogens	
are	 the	main	 factors	 that	may	 affect	 the	 course	 of	 psoriasis	 in	
pregnancy	and	that	are	also	necessary	to	maintain	the	pregnancy	
[11].
In	 pregnancy,	 Th1-dependent	 diseases	 such	 as	 psoriasis	
may	 be	 improving	 due	 to	 an	 increase	 in	 the	 participation	 of	
Th2	cells	compared	 to	Th1,	 resulting	 in	an	 increased	synthesis	
of	 interleukins	 Th2	 (IL-4,	 IL-5,	 IL-6,	 IL-9,	 IL-10,	 IL-13)	 and	

















reduces	 the	 number	 of	 neutrophils	 and	 Th1	 cells,	 and	 the	




(blocking	 factor),	what	has	 a	positive	effect	on	 the	 increase	of	
Th2	 cytokines	 production	 by	 peripheral	 blood	 lymphocytes	 of	
a	 pregnant	 woman.	As	 a	 result,	 reduced	 NK	 cell	 activity	 and	
increased	Th2-mediated	immune	response	are	observed	[21,	22].
On	the	other	hand,	psoriasis	can	cause	recurrent	miscarriages,	







common	 in	 the	 second	 trimester	 of	 pregnancy	 and	 can	 lead	 to	
fetal	death	or	preterm	delivery	[14,	23].
Treatment	of	psoriasis	in	pregnancy	is	individualized,	taking	
into	account	 the	extent	and	severity	of	 the	disease,	 the	benefits	
of	 therapy	 and	 the	 potential	 risk	 for	 the	mother	 and	 the	 fetus.	
Emollients	 and	 weak	 to	 moderately	 strong	 corticosteroids	 are	
used.	UVB	therapy	is	allowed	in	case	of	diffuse	lesions	[11].
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Contemporary	 definition	 of	 psychological	 stress	 claims	 it	




Pregnancy	 causes	 psychological	 stress,	 being	 associated	
with	 frustration,	 and	 leads	 to	 a	 number	 of	 internal	 conflicts.	 It	
is	 a	 source	of	 individual	 and	 social	pressures.	 It	 is	 a	period	of	
physical	 stress	associated	with	changes	 taking	place	within	 the	
endocrine,	immune	and	nervous	systems.	Pregnancy	can	change	
self-perception	 and	 cause	 lack	 of	 acceptance	 of	 the	 changing	






the	 patient,	 as	well	 as	 the	 coexistence	 of	 psoriasis	which	may	
cause	complications	and	symptoms	such	as	itching,	lead	to	high	
levels	of	stress	and	call	for	support	and	psychoprevention	[25].
Support	 is	 a	 multidimensional	 term,	 with	 the	 exchange	
of	 emotional	 support,	 information,	 tools	 and	 assets	 as	 its	
characteristic	feature.	This	exchange	may	be	unilateral	or	bilateral,	




minimizing	 these	 stressors,	 improving	 the	 ability	 to	 cope	with	
stress,	reducing	the	effect	of	a	stressful	situation	after	an	incident.	
Support	also	lowers	the	level	of	stress,	 thus	helping	the	patient	
to	 cope	 with	 a	 difficult	 situation.	 Perception	 and	 availability	























support,	 information,	 instrumental	 or	 tangible	 techniques,	 is	
interdisciplinary	 and	 challenging.	 It	 requires	 the	 medical	 staff	
to	be	able	 to	assess	 the	mental	 status	of	psoriatic	patients	and,	





  1. Sobjanek M, Mędrzycka-Dąbrowska W, Sokolowska-Wojdyło M, [et al.]. Skin diseases in 
pregnancy. W: The challenges of modern obstetrics. Red. Kiełbratowska B, Łysiał-Szydłowska 
W, Preis K. Gdańsk: Second International Conference, , 2007, 105-110.
  2.  Pawelczyk M, Karczewski J, Wiktorowicz K. T-regulatory cells CD4 + CD25 high peripheral 
blood of patients with psoriasis. Post Dermatol Alergol, 2010, 1, 27, 25-28.
  3.  Sęk H, Cieślak R. Social support - how to define, the types and sources of support, selected 
theoretical concepts. W: Social support, stress, health. Ed. Sek H, Cieslak R. Ed. Sciences. 
Warsaw: PWN, 2006, 11-29.
  4.  Skwara A Kolarzyk E. The role and importance of social support in coping with stress. 
Enviromental Med. 2002, 5, 15-18.
  5.  Baran A, Flisiak I, Sterling-Jaworowska M, Chodynicka B. Wpływ wybranych hormonów na 
patogenezę łuszczycy. Dermatol Review 2009, 96, 428-434.
  6.  Hirsch-Neneman A, Adamski Z. The development of research on various clinical and 
epidemiological aspects of systemic symptoms occurring in patients with psoriasis. Clinical 
Dermatol. 2010, 12, 187-192.
  7.  Hirsch-Neneman A, Adamski Z. Clinical Selected problems of systemic dysfunction in patients 
with psoriasis. Pract Dermatol. 2010, 5, 15-22.
  8.  Szepietowski J, Adamski Z, Chodorowska G, [et al.]. Diagnostics and treatment of psoriasis 
vulgaris, recommendations of experts of the Polish Society of Dermatology. Part I: mild psoriasis, 
psoriasis in children. Przegl Dermatol. 2012, 99, 83-96.
  9.  Kowzan-Korman A. Psoriasis-etiology and treatment. Medical News. 2003, 72, 223-227.
10.  Szepietowski J. Treatment of skin diseases and sexually transmitted diseases. Ed. Warsaw: 
PZWL, 2002.
11.  Dabrowska-Członka M, Chodorowska G. The course of psoriasis during pregnancy. New Med. 
2006, 1, 20-23.
12.  Żaba R, Samborski W, Adamski Z, Grzybowisk G. Immunopathogenesis and treatment of 
psoriasis. New Med. 2000, 69, 917-930.
13.  Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. 
J Dermatol Sci. 2005, 38, 1-7.
14.  Baran A, Flisiak I, Sterling-Jaworowska M, Chodynicka B. Effect of some hormones in the 
pathogenesis of psoriasis. Clin Dermatol. 2010, 12, 133-135.
15.  Boyd A, Morris L, Phillips C, Mentera M. Psoriasis and pregnancy: hormone and immune system 
interaction. Int J Dermatol. 1996, 35, 169-172.
16.  Piotrowska M. It is social support. New School. 2006, 2, 18-25.
17.  Raychaudhuri S, Navara T, Gross J, Raychaudhuri S. Clinical course of psoriasis During 
pregnancy. Int J Dermatol. 2003, 42, 518-520.
18.  Mowad C, Margolis D, Halpern A, [et al.]. Hormonal influences on women with psoriasis. Cutis. 
1998, 61, 257-260.
19.  Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and Regulatory T-Cell Paradigm in 
pregnancy. Am J Reprod Immunol. 2010, 63, 601-610.
20.  Schlaak J, Buslar M, Jochum W. T cell Buslau Involved in psoriasis vulgaris belong to the Th1 
subset. J Invest Dermatol. 1994, 102: 145-149.
21.  Malinowski A, Wilczynski JImmunologiczne mechanizmy utrzymania ciąży. Ginekol Prakt. 2003, 
73, 47-56.
22.  Szekeres-Bartho J, Barakonyi A, Par G, [et al.]. Progesterone as an immunomodulatory 
molecule. Int Immunopharmacol. 2001, 1, 1037-1048.
23.  Ben-David G, Sheiner E, Hallak M, Levi A. Pregnancy outcome of Patients with psoriasis. Am J 
Obstet Gynecol. 2005, 193, 347.
24.  Orzechowska A Talarowska M, Wysokiński A, [et al.]. Selected psychological factors in psoriasis 
and acne rosacea. Clin Dermatol. 2009, 11, 17-20.
25.  Pietrzak A, Janowski K, Lechowska-Mazur I, Krakow D. Psoriasis is a chronic skin disease in the 
context of psychology. New Med. 2006, 1, 14-19.
26.  Głaz S. Boulder role of stress in human development. Yearbook of Religious Education Section. 
2000, 160-170.
27.  Bąk K, Dyląg A, Gland, D, [et al.]. Stress - a companion of life. Man and the plague of the mind. 
Bielsko-Biała Ed. “PARK”, 2004.
28.  Dyga-Konarska M. Information and emotional support to patients by medical personnel. Stand 
Med. 2004, 5, 599-604.
29.  Fried R. Nonpharmacologic treatments in psychodermatology. Clin Dermatol. 2002, 20, 177-
185.
30. Podolska M, Majkowicz M, Sipak-Szmigiel O, Ronin-Walknowska E. Style radzenia sobie w 
sytuacjach stresowych a Lęk-stan i Lęk-cecha u kobiet z objawami depresji okołoporodowej. 
Ginekol Pol. 2009, 80, 201-206.
